Package Leaflet: Information for the User
Quetiapina Kern Pharma 50 mg Film-Coated Tablets
Read this package leaflet carefully before you start taking this medicine because it contains important information for you.
Quetiapinacontains a substance called quetiapine. It belongs to a group of medicines called antipsychotics.Quetiapinacan be used to treat several conditions, such as:
Your doctor may continue prescribing Quetiapina even when you are feeling better.
Do not take Quetiapina Kern Pharma:
If you have any doubts, consult your doctor or pharmacist before taking Quetiapina.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Quetiapina if:
Inform your doctor immediately if after taking Quetiapina you experience any of the following:
These conditions may be caused by this type of medication.
Inform your doctor as soon as possible if you have:
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase at the beginning of treatment, as all these medications take time to be effective, usually around two weeks but sometimes more. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information obtained from clinical trials has shown an increased risk of thoughts of suicide and/or suicidal behavior in young adults under 25 with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
With the use of this medication, very rarely reported severe skin reactions (SCARs) have been notified, which may put life at risk or be fatal. These usually manifest as:
If you develop these symptoms, stop using this medication and contact your doctor or seek medical attention immediately.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should regularly monitor your weight.
Children and adolescents
Quetiapine should not be used in children and adolescents under 18 years of age.
Other medications and Quetiapina
Inform your doctor if you are taking, have taken recently, or may need to take any other medication.
Do not take Quetiapina if you are using any of the following medications:
Inform your doctor if you are using any of the following medications:
Before stopping any of your medications, consult your doctor first.
Quetiapina with food, drinks, and alcohol
Quetiapine can be taken with or without food.
Be careful with the amount of alcohol you consume. This is because the combined effect of quetiapine and alcohol may make you drowsy.
Do not take grapefruit juice while taking Quetiapine. It may affect how the medication works.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, consult your doctor before using this medication. Do not take Quetiapina during pregnancy, unless you have consulted your doctor. Do not use Quetiapine if you are breastfeeding.
The following symptoms, which may represent withdrawal syndrome, may appear in newborns of mothers who have used quetiapine in the last trimester (last three months of their pregnancy): tremors, muscle stiffness, and/or weakness, drowsiness, agitation, respiratory problems, and feeding difficulties. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machinery
This medication may make you feel drowsy. Do not drive or operate tools or machines until you know how the medication affects you.
Quetiapine may cause symptoms such as drowsiness, dizziness, or visual disturbances, and decrease your reaction time. These effects, as well as the underlying condition, may impair your ability to drive vehicles or operate machinery. Therefore, do not drive, operate machinery, or engage in other activities that require special attention until your doctor assesses your response to this medication.
Quetiapina Kern Pharma contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Quetiapina Kern Pharma contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Effect on drug detection tests in urine
If you are undergoing a drug detection test in urine, taking quetiapine may produce positive results for methadone or certain antidepressant medications called tricyclic antidepressants (TCAs) when using some analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your illness and your needs, but will usually be between 150 mg and 800 mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Older adults
If you are an older adult, your doctor may change your dose.
Use in children and adolescents
Quetiapina should not be used in children and adolescents under 18 years of age.
If you take more Quetiapina Kern Pharma than you should
If you take more Quetiapina than your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or the nearest hospital immediately. Bring your Quetiapina tablets with you.
You can also call the Toxicological Information Service, Phone: 915620420, indicating the medication and the amount taken.
If you forget to take Quetiapina Kern Pharma
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed dose.
If you interrupt treatment with Quetiapina Kern Pharma
If you stop taking Quetiapina abruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before stopping treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Very rare side effects (may affect up to 1 in 10,000 people):
Not known (frequency cannot be estimated from available data)
The class of medicines to which quetiapine belongs can cause heart rhythm problems that can be serious and, in severe cases, fatal.
Some side effects are only seen when a blood test is done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or blood sugar, changes in the amount of thyroid hormones in the blood, increases in liver enzymes, decreases in the number of certain types of blood cells, decreases in the number of red blood cells, increases in creatine phosphokinase in the blood (a substance found in muscles), decreases in the amount of sodium in the blood, and increases in the amount of prolactin hormone in the blood. Increases in prolactin hormone may, in rare cases, lead to the following:
Side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through theSistema Español de Farmacovigilancia de Medicamentos de Uso Humano: https//www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require special conditions for conservation.
Medications should not be disposed of through drains or trash. Dispose of packaging and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
The active ingredient is quetiapine. The tablets contain 50 mg of quetiapine (as quetiapine fumarate).
The other components are:
Tablet core: Lactose monohydrate, Microcrystalline cellulose, Calcium hydrogen phosphate, Povidone, Carboxymethylcellulose sodium (Type A) from potato and Calcium stearate.
Tablet coating:Hydroxypropyl methylcellulose, Titanium dioxide (E171) and Triacetin.
Appearance of Quetiapina Kern Pharma and content of the packaging
The tablets are white, biconvex, round, 8 mm in diameter, and have a groove on one face.
The tablet can be divided into equal doses.
They are presented in PVC/aluminum blisters, in packs of 60 tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
Kern Pharma, S.L.
Venus, 72 - Pol. Ind.Colón II
08228 Terrassa - Barcelona
Spain
Responsible for manufacturing:
Laboratorios Alter S.A
Mateo Inurria, 30
28036 Madrid
Spain
Last review date of this leaflet: June 2024
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.